DVA vs TPCS · P/E 14, rev $12.82B vs rev $34.0M
DaVita HealthCare Partners Inc (DVA) versus TechPrecision Corporation Common stock (TPCS) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
TechPrecision Corporation Common stock (TPCS) is a metal fabrication company listed on NASDAQ.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported TPCS revenue for 2025-03-31 was $34.0M. Net income was -$2.7M. Revenue was up 7.7% from 2024-03-31 to 2025-03-31. TPCS currently screens at market cap $34.5M.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. TPCS currently screens at market cap $34.5M.
Not investment advice. Open the DVA and TPCS stock pages for the full models.
Not investment advice.